Postural Tachycardia Syndrome Clinical Trial
Official title:
Assessment of Objective Sleep Disturbances in Orthostatic Intolerance
Verified date | August 2018 |
Source | Vanderbilt University Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
We wish to study sleep architecture in patients with chronic orthostatic intolerance. We will test the null hypothesis that there is no difference in time during the various phases of sleep between patients and healthy control subjects.
Status | Completed |
Enrollment | 100 |
Est. completion date | December 2016 |
Est. primary completion date | December 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - diagnosed with chronic orthostatic intolerance (or healthy subject) Exclusion Criteria: - overt cause or acute orthostatic intolerance - pregnancy or lactation |
Country | Name | City | State |
---|---|---|---|
United States | Vanderbilt Unviersity | Nashville | Tennessee |
Lead Sponsor | Collaborator |
---|---|
Satish R. Raj | National Center for Research Resources (NCRR) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Duration of sleep | 1 night | ||
Secondary | Time in individual phases of sleep | 1 night | ||
Secondary | sleep latency | 1 might |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03124355 -
Vagal Stimulation in POTS
|
Phase 1 | |
Recruiting |
NCT04310644 -
Autonomic Small Fiber Neuropathy and Ehlers Danlos Syndromes - Prospective Study and Registry
|
||
Completed |
NCT03253120 -
Alterations of Attention in POTS Depending on Body Position and Hydration
|
N/A | |
Completed |
NCT03919773 -
IVIG (Gamunex-C) Treatment Study for POTS Subjects
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT01988883 -
Modafinil and Cognitive Function in POTS
|
Early Phase 1 | |
Active, not recruiting |
NCT01000350 -
Intravenous (IV) Saline and Exercise in Postural Tachycardia Syndrome (POTS)
|
N/A | |
Recruiting |
NCT00409435 -
A Study of Pyridostigmine in Postural Tachycardia Syndrome
|
Phase 2 | |
Completed |
NCT00770484 -
Effect of Exercise in OI
|
N/A | |
Terminated |
NCT00748228 -
Dopamine in Orthostatic Tolerance
|
N/A | |
Active, not recruiting |
NCT05630040 -
VNS for Long-COVID-19
|
N/A | |
Recruiting |
NCT04632134 -
Long-term Effects of Transcutaneous Vagal Nerve Stimulation on Postural Orthostatic Tachycardia Syndrome (POTS)
|
N/A | |
Completed |
NCT00685919 -
Peripheral Dopamine in Postural Tachycardia Syndrome
|
Phase 2/Phase 3 | |
Completed |
NCT00061009 -
Hypnosis in Autonomic Function
|
N/A | |
Recruiting |
NCT05618054 -
Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Natural History With Its Numerous Co-morbidities?
|
N/A | |
Completed |
NCT01366963 -
Cognitive Dysfunction in Postural Tachycardia Syndrome
|
N/A | |
Recruiting |
NCT05107635 -
Inappropriate Sinus Tachycardia Registry
|
||
Terminated |
NCT02154009 -
Clinical Autonomic Disorders: A Training Protocol
|
||
Completed |
NCT03602482 -
Standing Cognition and Co-morbidities of POTS Evaluation
|
N/A | |
Completed |
NCT02167412 -
EEG Characteristics in Youth POTS and/or Syncope
|
||
Active, not recruiting |
NCT00692471 -
Sleep Actigraphy in Postural Tachycardia Syndrome (POTS)
|